Clinical Study Details
Title | Type 1 Diabetes TrialNet: Oral Insulin Study |
Description | A study is being done to see if oral insulin could delay or prevent the onset of type 1 diabetes in individuals identified as being at a greater risk for developing the disease. In a prior study called the Diabetes Prevention Trial, there was evidence that individuals who tested positive at a certain level for a diabetes-related autoantibody called insulin autoantibody (IAA) benefited from the use of oral insulin. |
Eligibility | You (or your child) are eligible to be screened to determine your risk of developing type 1 diabetes if you (or your child) are a first degree blood relative (sibling, child, or parent) between the ages of 3 and 45 years or a second degree relative (cousin, uncle, aunt, niece, nephew, grandparent, or half-sibling) between 3 and 20 years of age. |
Procedures | Phase I screening involves a simple blood test for the presence of diabetes related autoantibodies which may appear years before type 1 diabetes develops. If you test positive for the insulin autoantibody and test positive for one or more of the other autoantibodies under investigation, you will be eligible to enter Phase 2 of the Natural History study which would involve having an oral glucose tolerance test, repeat autoantibody testing, and HLA evaluation (HLA is a gene involved in type 1 diabetes). |
Contact | If you are interested in having either you or your child screened for the Natural History Study and potential eligibility for this study, please contact Karen Barahona at (650) 723-5395 or by email at karenbb@stanford.edu to discuss any questions you may have and to schedule a screening appointment. Please visit the TrialNet public website at http://www.diabetestrialnet.org |
- Please review the consent form, as well as the TrialNet public website, for more information.
Brochure - Consent Form
- Assent Form for Ages 7-11
- Assent Form for Ages 12-17
- Patient Handbook
Spanish Documents:
TrialNet public website at http://www.diabetestrialnet.org